Source 20240722_182355
Canonical Links
| item | link |
|---|
| Direct transcription | 20240722_182355 |
| Raw photo | data/raw/photos/20240722_182355.jpg |
| field | value |
|---|
| Page label | Page 295 of 301 |
| Navigation path | Pipeline of GD & GBA-PD > GBA-PD > GBA Activator > Competitor |
| Section | GBA-PD, GD, and α-Synuclein Pipeline |
| Uncertain spans | 1 |
| Embedded images | 0 |
| Related photos | 2 |
Headings
- GCB-BTV Executive summary tempo code, Biodistribution Studies, Comp Bio E-selectin, Competitor (Roche / BIAL LTI-291 / NCT05819359 ACTIVATE)
- GCB BTV Executive summary: tempo code 43/6-100
- Biodistribution Studies
- Comp Bio
- Competitor
- Roche — GCB BTV (Gehrlein, 2023 #2475)
- BIAL (AGN-242647) (Lysosomal Therapeutics → BIAL)
- Clinical trial table
- GSL changes — Sato sho note
- GBA activation table (cell-free / iPSC-DaNs / SNCA tripl)
- Questions to BIAL
- Uncertain Spans
Wiki Coverage
Topic-level synthesis should link back to this source note or directly to the canonical transcription when making specific claims.